Navigation Links
Isis Pharmaceuticals to Present at the 23rd Annual Piper Jaffray Health Care Conference
Date:11/23/2011

CARLSBAD, Calif., Nov. 23, 2011 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at Piper Jaffray's Health Care Conference on Wednesday, November 30, 2011 at 8:00 a.m. ET at the New York Palace.

A live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's Web site, www.isispharm.com. A replay of the presentation will be available on the Isis Web site within 48 hours and will be archived for a limited time.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners. Isis' broad pipeline consists of 25 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic and severe and rare/neurodegenerative diseases, and cancer. Isis' partner, Genzyme, plans to commercialize Isis' lead product, mipomersen, following regulatory approval, which is expected in 2012. Isis' patents provide strong and extensive protection for its drugs and technology. Additional information about Isis is available at www.isispharm.com.


'/>"/>
SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. AcelRx Pharmaceuticals to Present at the 23rd Annual Piper Jaffray Health Care Conference
2. Questcor Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference on November 30, 2011
3. Cadence Pharmaceuticals Announces Completion of Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option by Underwriters
4. Avanir Pharmaceuticals to Participate in Piper Jaffray Health Care Conference
5. Isis to Receive Up to $14 Million from Pfizer for Its Acquisition of Excaliard Pharmaceuticals
6. Pacira Pharmaceuticals, Inc. Announces Completion of Follow-on Offering of Common Stock and Exercise of Over-Allotment Option
7. Global Markets for Marine-Derived Pharmaceuticals
8. Ferring Pharmaceuticals To Develop Major Corporate Center in Parsippany, New Jersey
9. Omthera Pharmaceuticals, Inc. to Present at the 23rd Annual Piper Jaffray Health Care Conference
10. Adeona Pharmaceuticals and Intrexon Announce Worldwide Exclusive Collaboration for Synthetic DNA-based Therapy for Pulmonary Arterial Hypertension
11. Kremers Urban Pharmaceuticals Inc. Announces Lipitor® Settlement Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015  According to Kalorama ... acquire Omnicare for approximately $12.7 billion fits a prevailing ... benefit from an aging population. The U.S. long term ... expected to continue as the aging population increases demand ... services. The healthcare market researcher,s report, The Long ...
(Date:5/28/2015)... 2015  Caris Life Sciences®, a leading biotechnology ... medicine, today announced the presentation of data from ... of Caris Molecular Intelligence®, the company,s panomic comprehensive ... resistance and pathway alterations in solid tumors. The ... at the annual meeting of the American Society ...
(Date:5/27/2015)... DUBLIN , May 27, 2015 /PRNewswire/ ... ) has announced the addition of the  ...   report to their offering.  ... provides a worldwide strategic overview of the ... regions, market segments and product categories. , ...
Breaking Medicine Technology:Kalorama: CVS Purchase of Omnicare Fits the Long Term Care Trend 2Kalorama: CVS Purchase of Omnicare Fits the Long Term Care Trend 3Kalorama: CVS Purchase of Omnicare Fits the Long Term Care Trend 4Caris Life Sciences Presents Large Cohort Biomarker Analyses that Characterizes Drug Resistances and Pathway Aberrations to Inform Targeted Anticancer Treatment Strategies 2Caris Life Sciences Presents Large Cohort Biomarker Analyses that Characterizes Drug Resistances and Pathway Aberrations to Inform Targeted Anticancer Treatment Strategies 3Caris Life Sciences Presents Large Cohort Biomarker Analyses that Characterizes Drug Resistances and Pathway Aberrations to Inform Targeted Anticancer Treatment Strategies 4Caris Life Sciences Presents Large Cohort Biomarker Analyses that Characterizes Drug Resistances and Pathway Aberrations to Inform Targeted Anticancer Treatment Strategies 5Global Orthopedics Market Strategies 2015 2
... 2011 The Coalition for Ethical Imaging (CEI), a ... practices in Texas, is supporting House Bill 1809, sponsored ... that will help rein in healthcare costs in the ... includes radiologists and other medical professionals, members of the ...
... Snow Jr., chairman and chief executive officer, Medco Health Solutions, ... the Citi 2011 Global Health Care Conference in New York ... The presentation at the Hilton, New York, will begin ... officer, is also scheduled to attend. The presentation ...
Cached Medicine Technology:Coalition for Ethical Imaging Advocates Diagnostic Imaging Reform in the 82nd Texas Legislature 2Coalition for Ethical Imaging Advocates Diagnostic Imaging Reform in the 82nd Texas Legislature 3Medco to Present at the Citi 2011 Global Health Care Conference 2
(Date:5/27/2015)... May 28, 2015 Calls Upon Individuals, Organizations ... A new nationwide initiative – a “Summer of Service” – ... and build partnerships to grow the number of individuals and ... its commitment to Veterans by inviting the community to visit ... June 29, 2015 from 1 – 3:00 p.m. in the ...
(Date:5/27/2015)... San Rafael, CA (PRWEB) May 27, 2015 ... Softball Camp director, Bree Nasti, the Adelphi University softball ... to the Divsion II Softball Championship since becoming a ... at 0-11, Adelphi University softball team turned it around ... Softball Championship. After defeating University of Central Missouri in ...
(Date:5/27/2015)... Down is a reputable source of 2015 NHL Western Conference ... middle of their series against the Anaheim Ducks with the Ducks ... can win tonight at home, this will tie up the series ... Honda Center in Anaheim. , During the regular season, the ... they won the Pacific Division by 8 points ahead of the ...
(Date:5/27/2015)... As the U.S. Supreme Court considers the ... the Affordable Care Act (ACA), an investigation by the ... RAND Corporation and Express Scripts provides an unprecedented look ... enrollees. , The analysis is published online as ... also appear in the journal’s June issue. , The ...
(Date:5/27/2015)... 2015 Khanna Vision Institute (KVI) announced the ... focussed on keratoconus eye disease . Keratoconus is commonly ... its onset in the teenage years. It worsens over the ... front clear part of the eye is defective. It becomes ... It results in poor vision which cannot even be corrected ...
Breaking Medicine News(10 mins):Health News:VA Begins “Summer of Service” to Bolster Volunteer Assistance for Veterans 2Health News:VA Begins “Summer of Service” to Bolster Volunteer Assistance for Veterans 3Health News:US Sports Camps and Nike Softball Camps Congratulate the Adelphi University Softball Team 2Health News:Blackhawks vs. Ducks NHL Western Conference Finals Tickets: Ticket Down Slashes Ticket Prices on Chicago Blackhawks vs. Anaheim Ducks 2015 NHL Western Conference Finals 2Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 2Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 3Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 4Health News:KVI announced the launch of The Keratoconus website focused on age based keratoconus treatment . 2
... (HealthDay News) -- Hormone levels at certain phases of the ... Researchers used MRI to study the brains of women ... pleasant, unpleasant or neutral. This test was repeated at different ... follicular stage of the menstrual cycle, no areas of the ...
... Reporter , TUESDAY, Oct. 26 (HealthDay News) -- Dr. Alexander Heazell ... their first child in 2001. They planned to name him Jack. ... wife,s blood pressure had shot up during the pregnancy, and at ... Losing the baby was devastating for Heazell and his wife. The ...
... and biologist Professor Cesare Montecucco, 62, of the Department ... has won the 100,000 euro Paul Ehrlich and Ludwig ... the field of bacterial diseases, including tetanus, botulism, anthrax ... by the Scientific Board of the Paul Ehrlich Foundation. ...
... scar tissue surrounding cancer tumours aims to provide new targets for ... deaths in the UK. Funded by the UK charity Pancreatic ... family of molecules present in this scar tissue - known as ... tumour growth. The project is led by surgeon and ...
... are common among the caregivers of children with a ... of a small study from the Johns Hopkins Children Center. ... researchers add. The study,s findings, published online in ... healthcare staff to do a better job in educating parents, ...
... (HealthDay News) -- Having a prostate-specific antigen (PSA) test to ... develops it will spread to other parts of the body, ... debate on whether PSA screenings actually improve survival rates or, ... that routine screening not only improves the patient,s quality of ...
Cached Medicine News:Health News:Stillbirth Can Be Devastating, Unpredictable 2Health News:Stillbirth Can Be Devastating, Unpredictable 3Health News:Professor Cesare Montecucco to receive the 2011 Paul Ehrlich and Ludwig Darmstaedter Prize 2Health News:Stroma may provide key to better cancer treatment 2Health News:Knowledge gaps, fears common among parents of children with drug-resistant bacteria 2Health News:Knowledge gaps, fears common among parents of children with drug-resistant bacteria 3Health News:PSA Test Reduces Risk of Spread if Prostate Cancer Strikes 2Health News:PSA Test Reduces Risk of Spread if Prostate Cancer Strikes 3
Sinskey lens manipulator, straight. Also available in titanium....
ICL manipulator with textured micro-ball tip....
... Keeler ophthalmoscopes are individually adjusted for perfect ... eye, not on paper. This, along with ... focus, ensures that whatever the patient's pupil ... largest field of view. Lithium-ion technology provides ...
The Beta 200S combines Heine's patented aspherical optics (U.S. Pat. 4.963.014) and a single-step Rekoss disk with a range of 36 to +38 dpt. to provide perfectly-focused images even in cases of high ...
Medicine Products: